ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Of Diabetic Nephropathy With Atrasentan (SONAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01858532
Recruitment Status : Terminated (Strategic considerations)
First Posted : May 21, 2013
Last Update Posted : April 26, 2018
Sponsor:
Information provided by (Responsible Party):
AbbVie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 29, 2018
  Actual Study Completion Date : March 29, 2018